文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

高密度脂蛋白胆固醇与低密度脂蛋白胆固醇和载脂蛋白 B100 水平低的女性心血管事件的相关性:一项队列研究。

Association of high-density lipoprotein cholesterol with incident cardiovascular events in women, by low-density lipoprotein cholesterol and apolipoprotein B100 levels: a cohort study.

机构信息

Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA.

出版信息

Ann Intern Med. 2011 Dec 6;155(11):742-50. doi: 10.7326/0003-4819-155-11-201112060-00006.


DOI:10.7326/0003-4819-155-11-201112060-00006
PMID:22147713
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3233986/
Abstract

BACKGROUND: Prior studies have found inverse associations between high-density lipoprotein cholesterol (HDL-C) or apolipoprotein A-I levels and cardiovascular disease (CVD). Whether this observation is consistent across low-density lipoprotein cholesterol (LDL-C) levels or total atherogenic particle burden (apolipoprotein B100) is less well-studied, particularly in women. OBJECTIVE: To determine the association between HDL-C or apolipoprotein A-I level and CVD across a range of LDL-C and apolipoprotein B100 values. DESIGN: Prospective cohort study. SETTING: The Women's Health Study, a cohort of U.S. female health professionals. PARTICIPANTS: 26,861 initially healthy women, aged 45 years or older at study entry (1992-1995), who were followed for a mean of approximately 11 years. MEASUREMENTS: Baseline lipids were measured directly, and apolipoproteins were measured with immunoassays. Outcomes were incident total CVD (n = 929), coronary events (n = 602), and stroke (n = 319). RESULTS: In multivariable analyses, HDL-C and apolipoprotein A-I levels were inversely associated with CVD and coronary events but not stroke. Adjusted coronary hazard ratios for decreasing quintiles of HDL-C were 1.00 (reference), 1.23 (95% CI, 0.85 to 1.78), 1.42 (CI, 0.98 to 2.06), 1.90 (CI, 1.33 to 2.71), and 2.19 (CI, 1.51 to 3.19) (P for linear trend < 0.001); corresponding hazard ratios for apolipoprotein A-I were 1.00 (reference), 0.98 (CI, 0.71 to 1.35), 1.02 (CI, 0.72 to 1.44), 1.37 (CI, 0.98 to 1.90), and 1.58 (CI, 1.14 to 2.20) (P for linear trend = 0.005). Consistent inverse associations were found for HDL-C with coronary events across a range of LDL-C values, including among women with low LDL-C levels. No associations were noted for HDL-C or apolipoprotein A-I among women with low apolipoprotein B100 values (<0.90 g/L). LIMITATION: Participants were at low risk for CVD, the number of events in the lowest apolipoprotein B100 stratum was small, only a single baseline measurement was obtained, and residual confounding may have occurred. CONCLUSION: Consistent inverse associations were found for HDL-C with incident coronary events among women with a range of LDL-C values. Among women with low total atherogenic particle burden (apolipoprotein B100 level <0.90 g/L), few events occurred and no associations were seen. PRIMARY FUNDING SOURCE: Merck & Co. and the National Heart, Lung, and Blood Institute and National Cancer Institute, National Institutes of Health.

摘要

背景:先前的研究发现高密度脂蛋白胆固醇(HDL-C)或载脂蛋白 A-I 水平与心血管疾病(CVD)呈负相关。然而,这种观察结果在低密度脂蛋白胆固醇(LDL-C)水平或总致动脉粥样硬化颗粒负担(载脂蛋白 B100)方面的一致性研究较少,尤其是在女性中。

目的:确定 HDL-C 或载脂蛋白 A-I 水平与不同 LDL-C 和载脂蛋白 B100 值范围内 CVD 的相关性。

设计:前瞻性队列研究。

地点:美国女性健康专业人员组成的妇女健康研究队列。

参与者:26861 名最初健康的女性,年龄在 45 岁或以上(1992-1995 年),平均随访约 11 年。

测量:基线脂质直接测量,载脂蛋白通过免疫测定法测量。结果是总 CVD(n=929)、冠心病事件(n=602)和中风(n=319)的发生。

结果:在多变量分析中,HDL-C 和载脂蛋白 A-I 水平与 CVD 和冠心病事件呈负相关,但与中风无关。HDL-C 五分位数降低的校正冠心病风险比为 1.00(参考)、1.23(95%CI,0.85 至 1.78)、1.42(CI,0.98 至 2.06)、1.90(CI,1.33 至 2.71)和 2.19(CI,1.51 至 3.19)(线性趋势 P<0.001);相应的载脂蛋白 A-I 风险比为 1.00(参考)、0.98(CI,0.71 至 1.35)、1.02(CI,0.72 至 1.44)、1.37(CI,0.98 至 1.90)和 1.58(CI,1.14 至 2.20)(线性趋势 P=0.005)。在 LDL-C 值的范围内,包括在 LDL-C 水平较低的女性中,均发现 HDL-C 与冠心病事件呈一致的负相关。在载脂蛋白 B100 值较低(<0.90 g/L)的女性中,未观察到 HDL-C 或载脂蛋白 A-I 的相关性。

局限性:参与者 CVD 风险较低,最低载脂蛋白 B100 分层的事件数量较少,仅获得单次基线测量,可能存在残余混杂。

结论:在 LDL-C 值范围内,HDL-C 与女性冠心病事件的发生呈一致的负相关。在总致动脉粥样硬化颗粒负担(载脂蛋白 B100 水平<0.90 g/L)较低的女性中,发生的事件较少,且未见相关性。

主要资金来源:默克公司和美国国立卫生研究院的国家心脏、肺和血液研究所以及国家癌症研究所。

相似文献

[1]
Association of high-density lipoprotein cholesterol with incident cardiovascular events in women, by low-density lipoprotein cholesterol and apolipoprotein B100 levels: a cohort study.

Ann Intern Med. 2011-12-6

[2]
Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low-Density Lipoprotein Cholesterol or Non-High-Density Lipoprotein Cholesterol.

J Am Heart Assoc. 2016-10-13

[3]
Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women.

JAMA. 2005-7-20

[4]
Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis.

PLoS Med. 2020-3-23

[5]
Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease.

Circulation. 2019-6-20

[6]
On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).

J Am Coll Cardiol. 2012-4-24

[7]
Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease.

Am J Cardiol. 2016-9-15

[8]
Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events.

Circulation. 2008-9-2

[9]
The apoB100/apoAI ratio is independently associated with the severity of coronary heart disease: a cross sectional study in patients undergoing coronary angiography.

Lipids Health Dis. 2015-11-18

[10]
Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease.

Circulation. 2018-11-20

引用本文的文献

[1]
Lipoprotein(a) and panvascular disease.

Lipids Health Dis. 2025-5-24

[2]
Plasma Biomarker Profiles for Premature and Nonpremature Coronary Heart Disease in Women.

Clin Chem. 2024-5-2

[3]
Discrepant effect of high-density lipoprotein cholesterol on esophageal and gastric cancer risk in a nationwide cohort.

Gastric Cancer. 2024-5

[4]
Effects of Tributyrin Supplementation on Liver Fat Deposition, Lipid Levels and Lipid Metabolism-Related Gene Expression in Broiler Chickens.

Genes (Basel). 2022-11-26

[5]
Association of lipid, inflammatory, and metabolic biomarkers with age at onset for incident cardiovascular disease.

BMC Med. 2022-11-10

[6]
Study on influencing factors of anthracycline-induced subclinical cardiotoxicity in DLBCL patients administered (R)-CHOP.

BMC Cancer. 2022-9-17

[7]
Association of Lipids, Lipoproteins, and Apolipoproteins with Stroke Subtypes in an International Case Control Study (INTERSTROKE).

J Stroke. 2022-5

[8]
Exposure-weighted scoring for metabolic syndrome and the risk of myocardial infarction and stroke: a nationwide population-based study.

Cardiovasc Diabetol. 2020-9-29

[9]
Sex-Related Differences of the Effect of Lipoproteins and Apolipoproteins on 10-Year Cardiovascular Disease Risk; Insights from the ATTICA Study (2002-2012).

Molecules. 2020-3-26

[10]
Anti-obesity effect of Yangkyuksanwha-tang in high-fat diet-induced obese mice.

BMC Complement Altern Med. 2019-9-5

本文引用的文献

[1]
Major lipids, apolipoproteins, and risk of vascular disease.

JAMA. 2009-11-11

[2]
High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies.

J Am Coll Cardiol. 2008-2-12

[3]
Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol.

J Am Coll Cardiol. 2008-1-1

[4]
High-density lipoprotein as a therapeutic target: a systematic review.

JAMA. 2007-8-15

[5]
The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence.

J Intern Med. 2006-5

[6]
Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies.

J Intern Med. 2006-5

[7]
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.

J Intern Med. 2006-3

[8]
Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.

Circulation. 2005-11-29

[9]
Apolipoprotein B versus non-high-density lipoprotein cholesterol: and the winner is..

Circulation. 2005-11-29

[10]
Perspectives on dyslipidemia and coronary heart disease in women.

J Am Coll Cardiol. 2005-11-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索